deferoxamine

基本解釋

Deferoxamine was used as an iron chelator.
去鐵胺被用做鐵的螯合劑。
Deferoxamine reduced brain atrophy and improved behavioral outcomes.
去鐵胺能減輕腦萎縮，改善行為后果。
The two most common iron chelators used currently to manage iron overload problems are an injectable form, deferoxamine and oral form, deferiprone.
目前最常見的兩種鐵螯合劑分別是注射式的去鐵敏的及口服式的去鐵酮。
These include insulin, sulfonylurea medications for type 2 diabetes, corticosteroids, diuretics, birth control pills, deferoxamine, rifampin, terbutaline, and propranolol.
這些藥品包括治療二型糖尿病的胰島素、磺尿類、皮質(zhì)甾類、利尿劑、避孕藥、雙胍藥、利福平、特普他林、心得安。
Objective: To evaluate the safety and efficacy of combining deferiprone(DFP)and deferoxamine(DFO)in iron chelation therapy in patients with thalassemia.
目的:探討去鐵酮(DFP)和去鐵胺(DFO)聯(lián)合用藥對(duì)重癥地中海貧血螯合治療的安全性和有效性。